Pathogenicity and virulence of Entamoeba histolytica, the agent of amoebiasis

ABSTRACTThe amoeba parasite Entamoeba histolytica is the causative agent of human amebiasis, an enteropathic disease affecting millions of people worldwide. This ancient protozoan is an elementary example of how parasites evolve with humans, e.g. taking advantage of multiple mechanisms to evade immu...

Full description

Bibliographic Details
Main Author: Nancy Guillén
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Virulence
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21505594.2022.2158656
_version_ 1797367150807089152
author Nancy Guillén
author_facet Nancy Guillén
author_sort Nancy Guillén
collection DOAJ
description ABSTRACTThe amoeba parasite Entamoeba histolytica is the causative agent of human amebiasis, an enteropathic disease affecting millions of people worldwide. This ancient protozoan is an elementary example of how parasites evolve with humans, e.g. taking advantage of multiple mechanisms to evade immune responses, interacting with microbiota for nutritional and protective needs, utilizing host resources for growth, division, and encystation. These skills of E. histolytica perpetuate the species and incidence of infection. However, in 10% of infected cases, the parasite turns into a pathogen; the host-parasite equilibrium is then disorganized, and the simple lifecycle based on two cell forms, trophozoites and cysts, becomes unbalanced. Trophozoites acquire a virulent phenotype which, when non-controlled, leads to intestinal invasion with the onset of amoebiasis symptoms. Virulent E. histolytica must cross mucus, epithelium, connective tissue and possibly blood. This highly mobile parasite faces various stresses and a powerful host immune response, with oxidative stress being a challenge for its survival. New emerging research avenues and omics technologies target gene regulation to determine human or parasitic factors activated upon infection, their role in virulence activation, and in pathogenesis; this research bears in mind that E. histolytica is a resident of the complex intestinal ecosystem. The goal is to eradicate amoebiasis from the planet, but the parasitic life of E. histolytica is ancient and complex and will likely continue to evolve with humans. Advances in these topics are summarized here.
first_indexed 2024-03-08T17:14:13Z
format Article
id doaj.art-cca67074de284fd88ac61cfd72ac457e
institution Directory Open Access Journal
issn 2150-5594
2150-5608
language English
last_indexed 2024-03-08T17:14:13Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Virulence
spelling doaj.art-cca67074de284fd88ac61cfd72ac457e2024-01-03T17:26:57ZengTaylor & Francis GroupVirulence2150-55942150-56082023-12-0114110.1080/21505594.2022.2158656Pathogenicity and virulence of Entamoeba histolytica, the agent of amoebiasisNancy Guillén0Cell Biology and Infection Department, Institut Pasteur and Centre National de la Recherche Scientifique CNRS-ERM9195, Paris, FranceABSTRACTThe amoeba parasite Entamoeba histolytica is the causative agent of human amebiasis, an enteropathic disease affecting millions of people worldwide. This ancient protozoan is an elementary example of how parasites evolve with humans, e.g. taking advantage of multiple mechanisms to evade immune responses, interacting with microbiota for nutritional and protective needs, utilizing host resources for growth, division, and encystation. These skills of E. histolytica perpetuate the species and incidence of infection. However, in 10% of infected cases, the parasite turns into a pathogen; the host-parasite equilibrium is then disorganized, and the simple lifecycle based on two cell forms, trophozoites and cysts, becomes unbalanced. Trophozoites acquire a virulent phenotype which, when non-controlled, leads to intestinal invasion with the onset of amoebiasis symptoms. Virulent E. histolytica must cross mucus, epithelium, connective tissue and possibly blood. This highly mobile parasite faces various stresses and a powerful host immune response, with oxidative stress being a challenge for its survival. New emerging research avenues and omics technologies target gene regulation to determine human or parasitic factors activated upon infection, their role in virulence activation, and in pathogenesis; this research bears in mind that E. histolytica is a resident of the complex intestinal ecosystem. The goal is to eradicate amoebiasis from the planet, but the parasitic life of E. histolytica is ancient and complex and will likely continue to evolve with humans. Advances in these topics are summarized here.https://www.tandfonline.com/doi/10.1080/21505594.2022.2158656Entamoebalifecyclestress responsesvirulencepathogenesis
spellingShingle Nancy Guillén
Pathogenicity and virulence of Entamoeba histolytica, the agent of amoebiasis
Virulence
Entamoeba
lifecycle
stress responses
virulence
pathogenesis
title Pathogenicity and virulence of Entamoeba histolytica, the agent of amoebiasis
title_full Pathogenicity and virulence of Entamoeba histolytica, the agent of amoebiasis
title_fullStr Pathogenicity and virulence of Entamoeba histolytica, the agent of amoebiasis
title_full_unstemmed Pathogenicity and virulence of Entamoeba histolytica, the agent of amoebiasis
title_short Pathogenicity and virulence of Entamoeba histolytica, the agent of amoebiasis
title_sort pathogenicity and virulence of entamoeba histolytica the agent of amoebiasis
topic Entamoeba
lifecycle
stress responses
virulence
pathogenesis
url https://www.tandfonline.com/doi/10.1080/21505594.2022.2158656
work_keys_str_mv AT nancyguillen pathogenicityandvirulenceofentamoebahistolyticatheagentofamoebiasis